Posts

Showing posts with the label Bullous Keratopathy market forecast

Bullous Keratopathy – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Bullous keratopathy is characterized by corneal stromal edema and the formation of epithelial or subepithelial bullae resulting from cell loss and endothelial decompensation. In more advanced stages, additional features such as subepithelial fibrosis, the development of a posterior collagenous layer (or retrocorneal fibrous membrane), and corneal vascularization may manifest. The condition leads to decreased vision due to the loss of corneal transparency, with accompanying symptoms like tearing and pain arising from ruptured epithelial bullae. Bullous keratopathy is the most prevalent indication for penetrating keratoplasty and regraft procedures. The primary cause of this condition is the loss of endothelial cells, particularly following ophthalmic surgeries such as cataract surgery. Thelansis’s “Bullous Keratopathy Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescr...